4//SEC Filing
Maimon Yossi 4
Accession 0000899243-22-000877
CIK 0001797336other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:05 PM ET
Size
5.5 KB
Accession
0000899243-22-000877
Insider Transaction Report
Form 4
Maimon Yossi
CFO
Transactions
- Award
Stock Option
2022-01-03+31,950→ 31,950 totalExercise: $9.11Exp: 2032-01-02→ Common Stock (31,950 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in sixteen substantially equal quarterly installments from the grants date, such that the option shall be fully vested on January 3, 2026.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
Related Parties
1- filerCIK 0001385115
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:05 PM ET
- Size
- 5.5 KB